UP STRATEGIC WEALTH INVESTMENT ADVISORS LLC

Position in ABBV — AbbVie Inc.

CIK 2011649 PITTSBURGH, PA

Back to ABBV Full portfolio

Position in ABBV

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$828,902

+$110,098 QoQ

Shares Held

3,294

-0.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.83%

of 13F equity value

Holder Rank

#2,721

of 4,153 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Common Shares in ABBV Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

UP STRATEGIC WEALTH INVESTMENT ADVISORS LLC holds $4,383,847 across 6 Drug Manufacturers - General names. ABBV ranks #2 (18.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,328	$1,592,843
2	ABBV	AbbVie Inc. This page	3,294	$828,902
3	JNJ	Johnson & Johnson	2,822	$716,703
4	GILD	Gilead Sciences, Inc.	4,700	$593,798
5	MRK	Merck & Co., Inc.	3,256	$418,396
6	AMGN	Amgen Inc	644	$233,205

All Filings in ABBV

Export CSV

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$828,902	3,294	-0.3%	Shares	Sole	2026-08-07
2026-03-31	$718,804	3,305	+15.9%	Shares	Sole	2026-05-12
2025-12-31	$651,653	2,852	0.0%	Shares	Sole	2026-02-10
2025-09-30	$660,352	2,852	-7.3%	Shares	Sole	2025-11-19
2025-06-30	$571,152	3,077	-2.4%	Shares	Sole	2025-08-12
2025-03-31	$660,616	3,153	+10.6%	Shares	Sole	2025-05-15
2024-12-31	$506,622	2,851	+23.3%	Shares	Sole	2025-02-14
2024-09-30	$456,771	2,313	+23.5%	Shares	Sole	2024-11-14
2024-06-30	$321,256	1,873	+13.7%	Shares	Sole	2024-08-12
2024-03-31	$300,100	1,648	0.0%	Shares	Sole	2024-05-15
2023-12-31	$255,390	1,648	—	Shares	Sole	2024-02-13
No filing history on record for this holder in this stock.